Home Pan Africa Four Cases of Mpox Detected in Britain: Risks to Public Remain Low

Four Cases of Mpox Detected in Britain: Risks to Public Remain Low

4
Four Cases of Mpox Detected in Britain: Risks to Public Remain Low

(3 Minutes Read)

The new variant of Mpox has also caused outbreaks in Burundi, Kenya, Rwanda, and Uganda. Single cases in travelers have also been reported in Sweden, India, Germany, and Thailand.

British health officials say they have identified four cases of the new, more infectious version of Mpox that first emerged in Congo. This is the first time the variant has caused a cluster of illnesses outside of Africa. British health officials, however, said the risk to the public remains low.

Authorities announced the first case of the new form of Mpox in the U.K. last week, saying the case was being treated at a London hospital. The persons afflicted with the diseases have traveled to countries in Africa, where there are incidences of ongoing outbreaks.

This week, the U.K. Health Security Agency said it had now identified three further cases who lived in the same household as the first patient. They too are now being treated at a hospital in London.

The new variant of Mpox was first detected earlier this year in eastern Congo. Scientists believe it causes milder symptoms that are harder to notice, which makes it easier to spread because people may not know they are infected. Its spread in Congo and elsewhere in Africa prompted the World Health Organization to declare a global emergency in August. Britian  recorded more than 3,000 cases of another type of Mpox during a 2022 outbreak that hit more than 100 countries.

The new variant of Mpox has also caused outbreaks in Burundi, Kenya, Rwanda, and Uganda. Single cases in travelers have also been reported in Sweden, India, Germany, and Thailand.

Read Also:

https://trendsnafrica.com/who-allocates-one-million-mpox-vaccines-for-africa/

To date, there have been about 43,000 suspect cases of Mpox in Africa, including more than 1,000 deaths. Most of the deaths were reported in Congo.     WHO said it had allocated 899,900 vaccine doses to nine African countries struggling with Mpox epidemics.